Search

everythinglearnresearchcommunity

for

Search:↓

Experts recommend thorough medical, sexual, and psychosocial assessments for women's sexual dysfunctions, and suggest individualized treatment plans with regular check-ups. They also mention potential use of estrogen and androgen therapy, but with caution due to safety concerns.

Testosterone may help increase sexual events for women with low libido due to antidepressants.

Certain SHBG gene variants, like rs727428, are linked to higher testosterone levels in women with PCOS.

Finasteride improves hair growth and reduces hirsutism in women, but side effects and optimal dosages need further research.

Testosterone therapy helped 63% of androgen-deficient women grow scalp hair, but more research is needed.

Hormonal changes and psychological issues can cause sexual dysfunction in postmenopausal women. Behavioral therapy is recommended first, with hormone replacement helping some symptoms but not libido. Testosterone can improve libido, but its effects on overall sexual function are unclear. Emotional and relationship issues should be addressed before using medication, and the benefits and risks of testosterone supplementation should be considered.

Taking spironolactone and linestrenol for androgen excess can lead to lower bone density in young women.

Men are more likely to have severe COVID-19 cases and fatalities than women due to factors like lifestyle, aging, and biological differences.

FFA is more common in postmenopausal women, can affect younger women, and may stabilize over time.

Low vitamin D levels can significantly contribute to hair loss, especially in women aged 35-45. Correcting these levels early may help prevent and treat this condition.

Hair loss in women can be slowed with treatment, but more research needed for better solutions.

Hair loss in women linked to higher sexual dysfunction risk.

Iron deficiency common in women, not always linked to hair loss; more research needed.

The conclusion is that removing both ovaries is the best treatment for excess male hormones in postmenopausal women, with medication as another option, and managing insulin resistance is important for diagnosis and treatment.

Some women with excess hair growth have a hormone condition that can't be diagnosed by blood or urine tests alone.

Hair loss in women is genetic, diagnosed by examination and biopsy, and treated with minoxidil, finasteride, or transplantation.

FPHL causes hair loss in women due to genetics and hormones; minoxidil and anti-androgens are treatments, and early intervention is advised.

Over 50% of women over 50 experience hair loss, with minoxidil being the only proven effective treatment.

Testosterone therapy can help women with androgen deficiency by improving energy, sex drive, and bone health with few side effects.

Formestane is a preferred second-line treatment for advanced breast cancer in postmenopausal women because it's effective and has fewer side effects.

Women with PCOS are more likely to have impaired glucose tolerance and type 2 diabetes, especially if they are Asian or obese.

Finasteride with oral contraceptive helps improve hair loss in premenopausal women.

Women's ovarian hormones and adrenal androgens change throughout life, affecting hair loss and health.

Women with female-pattern baldness produce more testosterone, but 5a-reductase inhibition treatment won't help.

Frontal fibrosing alopecia in Brazil mostly affects postmenopausal women, often linked with hypothyroidism and eyebrow hair loss.

Women's hair gets thinner and grayer as they age, with treatments available for hair loss and graying.

Testosterone's role in women's sex drive is unclear and needs more research, as low levels don't always mean less sexual interest and high levels can cause side effects.

Laser treatment increases hair density and thickness safely in women with hair loss.

Transdermal testosterone can improve sexual desire in postmenopausal women but lacks long-term safety data and is not FDA-approved for this use.

Certain gene variants may contribute to high androgen levels in women with polycystic ovary syndrome.